The spike protein (S protein) & spike mRNA both can enter the nucleus of cell; did you know that? did anyone involved with mRNA technology tell you? Sattar et al. warned us; we can extrapolate that

by Paul Alexander

spike protein and MOD mRNA from mRNA technology gene injection can also enter the cell's nucleus from the cytoplasm; as well as reverse transcribes into DNA & passed on from generation to generation

Did they manipulate and design the mRNA in such a way to deliberately enter the nucleus, as well as the spike protein? Was this deliberate and did they always know yet were silent?

i)Sattar et al:

Nuclear translocation of spike mRNA and protein is a novel pathogenic feature of SARS-CoV-2 | bioRxiv


Although the S protein is a surface transmembrane type 1 glycoprotein, it has been predicted to be translocated into the nucleus due to the novel nuclear localization signal (NLS) “PRRARSV”, which is absent from the S protein of other coronaviruses. Indeed, S proteins translocate into the nucleus in SARS-CoV-2-infected cells. To our surprise, S mRNAs also translocate into the nucleus. S mRNA colocalizes with S protein, aiding the nuclear translocation of S mRNA.’

ii) Aldén et al:

CIMB | Free Full-Text | Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line (

‘Results indicate a fast up-take of Pfizer (BNT162b2) into human liver cell line Huh7, leading to changes in LINE-1 expression and distribution. We also show that BNT162b2 mRNA is reverse transcribed intracellularly into DNA in as fast as 6 h upon BNT162b2 exposure.’

iii)Domazet-Lošo et al:

Genes | Free Full-Text | mRNA Vaccines: Why Is the Biology of Retroposition Ignored? (

‘Here, I discuss the pervasive claim that mRNA-based vaccines cannot alter genomes. Surprisingly, this notion is widely stated in the mRNA vaccine literature but never supported by referencing any primary scientific papers that would specifically address this question. This discrepancy becomes even more puzzling if one considers previous work on the molecular and evolutionary aspects of retroposition in murine and human populations that clearly documents the frequent integration of mRNA molecules into genomes, including clinical contexts.’